COVID-19 vaccines: labels updated for myocarditis and pericarditis risk
In plain language
This advisory involves Pfizer-BioNTech and Moderna COVID-19 vaccines in Canada. Health Canada has updated vaccine labels to include information on very rare reports of myocarditis and pericarditis. Seek medical attention if you experience symptoms after vaccination.
What to do
- Seek medical attention immediately if you experience chest pain, shortness of breath, or a fast-beating heart within several days of vaccination.
- Report any adverse events after immunization to your healthcare professional.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Risk of myocarditis and pericarditis
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Risk of myocarditis and pericarditis
What should consumers do?
Seek medical attention immediately if you experience chest pain, shortness of breath, or a fast-beating heart within several days of vaccination. Report any adverse events after immunization to your healthcare professional.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Risk of myocarditis and pericarditis
When was this product recalled?
This product was recalled on June 30, 2021.
Is the Pfizer-BioNTech and Moderna brand affected by this recall?
Yes, Pfizer-BioNTech and Moderna products are affected by this recall. This advisory involves Pfizer-BioNTech and Moderna COVID-19 vaccines in Canada. Health Canada has updated vaccine labels to include information on very rare reports of myocarditis and pericarditis. Seek medical attention if you experience symptoms after vaccination.